Publication | Closed Access

Matrix metalloproteinases and their tissue inhibitor after reperfused ST-elevation myocardial infarction treated with doxycycline. Insights from the TIPTOP trial

Percutaneous Coronary InterventionThrombosisCardiovascular DiseaseMedicineMatrix MetalloproteinasesTissue InhibitorPharmacotherapyTiptop TrialPharmacologyCardiologyCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction